TREATMENT OF VASCULAR COMPLICATIONS OF DIABETES
    24.
    发明公开
    TREATMENT OF VASCULAR COMPLICATIONS OF DIABETES 审中-公开
    BEHANDLUNGVASKULÄRERKOMPLIKATIONEN VON糖尿病

    公开(公告)号:EP2582385A1

    公开(公告)日:2013-04-24

    申请号:EP10771018.8

    申请日:2010-10-20

    IPC分类号: A61K38/19 C07K7/64 C07K14/525

    CPC分类号: C07K14/525 A61K38/12

    摘要: A peptide consisting of 7-17 amino acids and including the adjacent hexamer TX
    1 EX
    2 X
    3 E, where X
    1 , X
    2 and X
    3 can be any natural or non natural amino acid, wherein the peptide does not exhibit TNF-receptor-binding activity and is cyclic, for the treatment or prevention of vascular complications in diabetes patients.

    摘要翻译: 由7-17个氨基酸组成并包含相邻的六聚体TX 1 EX 2 X 3 E的肽,其中X 1,X 2和X 3可以是任何天然或非天然氨基酸,其中所述肽不显示TNF-受体 结合活性,是循环的,用于治疗或预防糖尿病患者的血管并发症。

    Treatment of vascular complications of diabetes
    25.
    发明公开
    Treatment of vascular complications of diabetes 有权
    BehandlungvaskulärerKomplikationen von Diabetes

    公开(公告)号:EP2397151A1

    公开(公告)日:2011-12-21

    申请号:EP10166637.8

    申请日:2010-06-21

    IPC分类号: A61K38/19 C07K7/64 C07K14/525

    CPC分类号: C07K14/525 A61K38/12

    摘要: A peptide consisting of 7-17 amino acids and including the adjacent hexamer TX 1 EX 2 X 3 E, where X 1 , X 2 and X 3 can be any natural or non natural amino acid, wherein the peptide does not exhibit TNF-receptor-binding activity and is cyclic, for the treatment or prevention of vascular complications in diabetes patients.

    摘要翻译: 由7-17个氨基酸组成并包含相邻的六聚体TX 1 EX 2 X 3 E的肽,其中X 1,X 2和X 3可以是任何天然或非天然氨基酸,其中所述肽不显示TNF-受体 结合活性,是循环的,用于治疗或预防糖尿病患者的血管并发症。

    REVERSES PROTEIN
    26.
    发明公开
    REVERSES PROTEIN 有权
    反转蛋白

    公开(公告)号:EP2219663A1

    公开(公告)日:2010-08-25

    申请号:EP08858971.8

    申请日:2008-12-12

    IPC分类号: A61K38/19 C07K14/525

    摘要: The invention relates to a protein the N-terminal end of which is composed of one or more C-terminal parts of the amino acid sequence of the mature tumor necrosis factor, and the C-terminal end of which is composed of one or more N-terminal parts of the amino acid sequence of the mature tumor necrosis factor. The protein activates epithelial ion channels and improves the pulmonary function and can be used to produce drugs for the treatment of diseases that are associated with the pulmonary function, such as oedema.